BPA Master - Reagents for Luminex 3D
Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/b1bd4e02cf314bf2a3de237f6b9ba74f/view
Timeline
    Description

    The Defense Health Agency (DHA) intends to establish a Blanket Purchase Agreement on a sole source basis with One Lambda, Inc. for the procurement of laboratory reagents essential for the Luminex 3D Instrument System. This procurement is justified under the statutory authority permitting Other than Full and Open Competition, as outlined in FAR 6.302-1, indicating that only One Lambda can meet the agency's specific requirements. The reagents are crucial for immunology testing and transplantation compatibility, supporting the operations of the Immunology Lab Department at Walter Reed National Military Medical Center. Interested parties capable of providing the requested reagents must submit their capabilities and pricing by 10:00 am EST on November 8, 2024, via email to the designated contacts, Ealed Nuru and Erica S. Oh.

    Files
    Title
    Posted
    One Lambda SPECIAL NOTICE - WRNMMC.docx
    The Defense Health Agency (DHA) intends to establish a Blanket Purchase Agreement on a sole source basis with One Lambda, Inc. for the procurement of lab reagents essential for the Luminex 3D Instrument System. This decision occurs under the statutory authority allowing Other than Full and Open Competition, as specified in FAR 6.302-1, indicating that only one source meets the agency's requirements. The announcement clarifies that it does not constitute a request for competitive proposals, and submissions for alternate proposals or inquiries will not be acknowledged. Interested parties capable of supplying the required reagents may present their capabilities and pricing by 10:00 am EST on November 8, 2024, via specified email addresses. The document emphasizes that the government will determine whether a competitive procurement is in its best interest based solely on the received expressions of capability.
    PDF One Lambda Price List.pdf
    The document outlines a pricing list associated with various laboratory tests and controls, primarily focusing on HLA (human leukocyte antigen) typing and antibody detection. The itemized list includes specific products, such as the LABType™ and FlowPRA™ tests, along with their respective prices ranging from $59.70 for basic controls to $27,304.86 for the AllType™ FASTplex™ NGS 11 Loci Flex Kit. Each product is essential for DNA typing, screening, and verifying HLA compatibility, which is crucial in transplantation and immunology. The list is structured straightforwardly, presenting each item number, description, and price. This pricing document likely serves the context of government Requests for Proposals (RFPs) or grants, indicating the cost of necessary laboratory supplies and services to support biomedical research, transplant medicine, or related healthcare initiatives. The detailed breakdown ensures clarity in procurement processes, allowing government entities to evaluate and select solutions aligned with federal or state funding requirements. Overall, the document emphasizes the cost and availability of essential laboratory resources for advancing healthcare and research initiatives.
    Lifecycle
    Title
    Type
    BPA Master - Reagents for Luminex 3D
    Currently viewing
    Special Notice
    Similar Opportunities
    CHEMISTRY AND IMMUNOASSAY TESTING PROGRAM
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is planning to issue a sole source award contract to Roche Diagnostics Corporation for the Chemistry and Immunoassay Testing Program. This program is intended to sustain the use of three Chemistry and Immunochemistry Systems under a Cost Per Reportable Result (CPRR) agreement or Cost Per Reagent Pack. The program includes equipment, reagents, tools, materials, training, and a water purification system, Uninterruptible Power Supply (UPS), and services necessary to meet the Chemistry and Immunochemistry testing and analysis requirements for Walter Reed National Military Medical Center (WRNMMC) laboratories. The anticipated period of performance is five years.
    Medical Reagents for USNH Okinawa
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) Troop Support is seeking qualified vendors to provide medical reagents and consumables for the United States Naval Hospital (USNH) Okinawa, Japan. This procurement involves an Indefinite Delivery, Indefinite Quantity (IDIQ) contract for Class VIII medical supplies, specifically tailored for the laboratory operations utilizing VITROS Chemistry Analyzers. The contract, valued at approximately $5 million, is crucial for ensuring the availability of specialized medical supplies that meet stringent safety and quality standards, thereby supporting the healthcare needs of military personnel. Interested vendors must submit their electronic quotes by November 29, 2024, at 8:00 am Japan Standard Time, along with required documentation, to the primary contact, Bradley Ah Nee, at bradley.ahnee@dla.mil.
    Blood Testing Supplies and Services
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), intends to award a sole source contract to Vitalant for blood testing supplies and services at the David Grant Medical Center (DGMC) located at Travis Air Force Base in California. The contract aims to provide essential blood products and services, ensuring compliance with FDA and AABB standards, and includes a six-month base period starting April 1, 2025, with four optional one-year extensions and a potential six-month extension thereafter. These services are critical for maintaining mission readiness and patient care within military healthcare settings, emphasizing the need for 24/7 availability and rapid response times for urgent requests. Interested parties must submit capability statements by 10:00 AM Pacific Daylight Time on October 31, 2024, to Danielle Patterson at danielle.l.patterson3.civ@health.mil, adhering to specific formatting requirements.
    BD Biosciences Proprietary Instrumentation Package and Reagent Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure a proprietary instrumentation package and reagent kits from Becton, Dickinson & Company for the Department of Laboratory Medicine. This acquisition aims to secure essential supplies, including instrument rentals and quality control materials, necessary for the operation of the Hematology Flow Cytometry Service, which plays a critical role in patient care and research. The procurement is vital for maintaining the laboratory's capacity to deliver timely and accurate results, as the specified reagent kits are uniquely compatible with the existing BD Rhapsody™ single cell analysis system. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 6:30 AM EST, as this is a presolicitation notice and not a request for quotations.
    6550--Brand Name Beckman Coulter Navios Flow Cytometer reagents and supplies
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 16, intends to procure brand-name Beckman Coulter Navios Flow Cytometer reagents and supplies through a Blanket Purchase Agreement (BPA) for a duration of five years. This procurement is aimed at supporting the Central Arkansas Veterans Healthcare System, with products ordered on an as-needed basis, including various cytometer reagents and controls essential for diagnostic purposes. Interested parties are required to demonstrate their capability to meet the specified requirements, including providing an authorization letter from Beckman Coulter and ensuring timely delivery, with responses due by November 12, 2024, and an anticipated award date of December 1, 2024. For inquiries, interested vendors should contact Contracting Officer Anthony Marion at anthony.marion2@va.gov by November 6, 2024.
    Coagulation reagents, consumables, maintenance, and the lease of Stago Analyzers
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the procurement of coagulation reagents, consumables, maintenance services, and the lease of Stago analyzers for the U.S. Naval Hospital in Guam. The contract, designated HT941025Q2004, aims to ensure the hospital is equipped with essential laboratory supplies and services necessary for effective patient care, with delivery and installation expected between January 1, 2025, and September 30, 2025, and options extending through September 2029. This procurement is critical for maintaining the hospital's operational efficiency and compliance with federal regulations, emphasizing the importance of quality and timely delivery of medical supplies. Interested contractors must submit their quotes electronically by 9:00 am PDT on November 12, 2024, and can reach out to Uyen Tran or Renier Valdez for further inquiries.
    Microbial Testing Supplies - Bridge Contract
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    6550--Lexington Ortho Clinical Diag - Blood Bank
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the Network Contracting Office 9, intends to award a sole source contract to Ortho Clinical Diagnostics for the provision of specific reagents and consumables necessary for the ORTHO Vision Swift ID-Micro Typing System at the Lexington VA Medical Center. This procurement is critical as Ortho Clinical Diagnostics is the only manufacturer capable of supplying products that are compatible with the existing equipment, ensuring the effective operation of the blood bank services. Interested vendors are invited to submit capability statements by 10:00 a.m. CT on November 15, 2024, to james.moore20@va.gov; however, this notice does not constitute a competitive solicitation, and the government retains discretion over the procurement process.
    Sources Sought-BioFire Reagents and Test Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is conducting a Sources Sought announcement to identify potential qualified small businesses capable of supplying BioFire Defense reagents and test kits. The NIH's Department of Laboratory Medicine requires these reagents for their BioFire FilmArray analyzers, which are essential for the rapid detection of infectious agents from clinical samples, thereby facilitating timely treatment. Interested vendors must submit their company information, including a capability statement, by 12:00 PM EST on November 7, 2024, to Sheri Eiri at sheri.eiri@nih.gov, as the government will not reimburse any costs associated with this request.
    Notice of Intent to Sole Source INTERCEPT Blood System for Platelets
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, intends to award a sole source Firm-Fixed-Price contract to CERUS Corporation for the procurement of the INTERCEPT Blood System for Platelets. This system is a commercial-off-the-shelf (COTS) product essential for ensuring the safety and efficacy of platelet transfusions, which is critical for patient care in military medical facilities. The contract will cover a base year from January 1, 2025, to December 31, 2025, with an estimated total value of $210,816.00, and will include two option years. Interested parties may submit evidence demonstrating that competition would be beneficial to the Government, but the decision to proceed with a competitive procurement rests solely with the Government. For inquiries, contact Cynthia Scharnowske at cynthia.e.scharnowske.civ@health.mil, and please reference "Notice of Intent Submission 12160537" in the subject line.